Consortium
Quantimony is configured as a multi-site network comprising eleven internationally-renowned research teams as beneficiaries: seven universities, one research institute, two large corporations and one SME. It is enhanced by fourteen partner organizations, six of which are industrial partners, four are large scale research facilities and three are internationally-leading academic groups. The combined consortium spans eleven countries: eight European, plus USA, Taiwan and Brazil.
Via Quantimony, the beneficiaries and partner organisations will cooperate to prepare a new cohort of researchers to jointly instigate the transition of III-Sb materials from their current status of high-performance, high-cost niche application towards scalable and industrially relevant technologies.